| P2093 | author name string | Joseph McBride | |
| | Dick Slater | |
| | Rajah Koppala | |
| | Sushama Kunnathil | |
| P2860 | cites work | Prostaglandins, NSAIDs, and Gastric Mucosal Protection: Why Doesn't the Stomach Digest Itself? | Q22306448 |
| | COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression | Q24536398 |
| | Evidence that intrathecal morphine-3-glucuronide may cause pain enhancement via toll-like receptor 4/MD-2 and interleukin-1beta | Q24656645 |
| | 75 years of opioid research: the exciting but vain quest for the Holy Grail | Q24670315 |
| | Brief history of antipyretic therapy | Q28139956 |
| | Reye's syndrome: the case for a causal link with aspirin | Q28211899 |
| | Choosing nonselective NSAIDs and selective COX-2 inhibitors in the elderly. A clinical use pathway | Q28218875 |
| | Opioid metabolism | Q28250437 |
| | Opioid-induced hyperalgesia: a qualitative systematic review | Q28299687 |
| | Methylnaltrexone for opioid-induced constipation in advanced illness | Q33439945 |
| | NMDA-receptor antagonists and opioid receptor interactions as related to analgesia and tolerance | Q33844801 |
| | Adjuvant analgesics in cancer pain management | Q33982292 |
| | The development of gastrointestinal-sparing nonsteroidal anti-inflammatory drugs | Q34318614 |
| | Postoperative epidural opioid analgesia: what are the choices? | Q34399705 |
| | Spinal G-protein-gated potassium channels contribute in a dose-dependent manner to the analgesic effect of mu- and delta- but not kappa-opioids. | Q34409452 |
| | Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group. | Q34459461 |
| | AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association | Q34741065 |
| | Paracetamol (Acetaminophen): mechanisms of action | Q34834887 |
| | G protein inactive and active forms investigated by simulation methods | Q34906286 |
| | Peripheral mechanisms of opioid analgesia | Q34926296 |
| | Treatment of neuropathic pain: an overview of recent guidelines | Q35006269 |
| | Opioid receptors and opioid peptide-producing leukocytes in inflammatory pain--basic and therapeutic aspects | Q35010637 |
| | Opioid receptors in the gastrointestinal tract | Q35185222 |
| | Cyclooxygenase-3: axiom, dogma, anomaly, enigma or splice error?--Not as easy as 1, 2, 3. | Q35887563 |
| | Opioids in neuropathic pain | Q36264640 |
| | RGS proteins have a signalling complex: interactions between RGS proteins and GPCRs, effectors, and auxiliary proteins | Q36286972 |
| | The molecular toxicology of acetaminophen | Q36360808 |
| | Opioid-induced abnormal pain sensitivity | Q36405690 |
| | Principles of control of cancer pain. | Q36462598 |
| | Pharmacological aspects of successful long-term analgesia | Q36495288 |
| | Narrative review: the pathophysiology of fibromyalgia | Q36821849 |
| | Complicated pain management in a CYP450 2D6 poor metabolizer | Q36994597 |
| | Physiological regulation of prostaglandins in the kidney | Q36995536 |
| | Efficacy of opioids for chronic pain: a review of the evidence | Q37198520 |
| | Opioid rotation in patients with cancer: a review of the current literature. | Q37287628 |
| | New approaches to the treatment of opioid-induced constipation. | Q37299608 |
| | Evaluation of the mu and kappa opioid actions of butorphanol in humans through differential naltrexone blockade | Q37397149 |
| | Pain medicine position paper | Q37601510 |
| | Endogenous opiates and behavior: 2008. | Q37606040 |
| | Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes | Q39307077 |
| | Comparison of intravenous nalbuphine infusion versus naloxone in the prevention of epidural morphine-related side effects | Q39444357 |
| | Heterodimerization of ORL1 and opioid receptors and its consequences for N-type calcium channel regulation. | Q39779553 |
| | Pharmacologic treatment of cancer pain | Q41115628 |
| | Stimulating the development of mechanism-based, individualized pain therapies | Q43066442 |
| | Activation of the opioidergic descending pain control system underlies placebo analgesia. | Q43285483 |
| | Sex hormone suppression by intrathecal opioids: a prospective study | Q44016972 |
| | The role of methadone in opioid rotation-a Polish experience | Q44340849 |
| | Short-term infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal | Q44343251 |
| | Adenosine contributes to mu-opioid synaptic inhibition in rat substantia gelatinosa in vitro | Q44348019 |
| | Prescribing methadone, a unique analgesic | Q45035163 |
| | Absorption characteristics of transdermally administered fentanyl | Q46451473 |
| | Recent considerations in nonsteroidal anti-inflammatory drug gastropathy | Q46924071 |
| | New culprits in chronic pain | Q48421843 |
| | Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: implication for renal function. | Q52195455 |
| | Risk of Death or Reinfarction Associated With the Use of Selective Cyclooxygenase-2 Inhibitors and Nonselective Nonsteroidal Antiinflammatory Drugs After Acute Myocardial Infarction | Q57260454 |
| | Aspirin use and the risk for colorectal cancer and adenoma in male health professionals | Q72075313 |
| | Differential regulation of renal cyclooxygenase mRNA by dietary salt intake | Q73831587 |
| | Mechanism of action of nonsteroidal anti-inflammatory drugs | Q77420424 |
| | Selective COX-2 inhibition markedly slows disease progression and attenuates altered prostanoid production in Han:SPRD-cy rats with inherited kidney disease | Q80405816 |
| P433 | issue | 4 | |
| P304 | page(s) | 400-411 | |
| P577 | publication date | 2010-12-01 | |
| P1433 | published in | Seminars in interventional radiology | Q26842882 |
| P1476 | title | Pharmacology of nonsteroidal antiinflammatory drugs and opioids | |
| P478 | volume | 27 | |